checkAd
    Startseite > Aktien > Lifecore Biomedical > Nachrichten
    Lifecore Biomedical Aktie
    6,4400
     
    USD
    +0,31 %
    +0,0200 USD
    Letzter Kurs 02:00:00 Nasdaq
    6,4400
     
    USD
    200 STK
    Geldkurs 01.05.24
    6,4700
     
    USD
    100 STK
    Briefkurs 01.05.24
    ISIN: US5147661046 · WKN: 899376 · SYM: LFCR · USA

    Neueste Nachrichten

    Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
    19.04.24 · globenewswire · Lifecore Biomedical
    ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
    11.04.24 · Business Wire (engl.) · Lifecore Biomedical
    Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
    01.04.24 · globenewswire · Lifecore Biomedical
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors
    28.03.24 · Business Wire (engl.) · Lifecore Biomedical
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors
    28.03.24 · Business Wire (engl.) · Lifecore Biomedical
    Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    28.03.24 · Business Wire (engl.) · Lifecore Biomedical
    The Law Offices of Frank R. Cruz Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors
    27.03.24 · Business Wire (engl.) · Lifecore Biomedical
    Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
    26.03.24 · globenewswire · Lifecore Biomedical
    Lifecore Class Action Lawsuit Investigation News – Potential to Make Claim, Recover Losses, Contact Johnson Fistel, LLP
    24.03.24 · Business Wire (engl.) · Lifecore Biomedical
    Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    21.03.24 · Business Wire (engl.) · Lifecore Biomedical
    Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Lifecore Biomedical, Inc. (LFCR)
    21.03.24 · Business Wire (engl.) · Lifecore Biomedical
    Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
    20.03.24 · globenewswire · Lifecore Biomedical